Why the study?
Few elderly patients are included in clinical trials, leaving current clinical practice guidelines without specific recommendations for this population.
Comprehensive geriatric assessment and individualized cardiovascular prevention strategies are essential for managing elderly patients ≥ 75 years with high cardiovascular risk.
Provides interim guidance for CV prevention in adults ≥75 years where guidelines are silent; leaves open need for dedicated RCTs.
In recent decades, life expectancy has been increasing significantly. In this scenario, health interventions are necessary to improve prognosis and quality of life of elderly with cardiovascular risk factors and cardiovascular disease. However, the number of elderly patients included in clinical trials is low, thus current clinical practice guidelines do not include specific recommendations. This document aims to review prevention recommendations focused in patients ≥ 75 years with high or very high cardiovascular risk, regarding objectives, medical treatment options and also including physical exercise and their inclusion in cardiac rehabilitation programs. Also, we will show why geriatric syndromes such as frailty, dependence, cognitive impairment, and nutritional status, as well as comorbidities, ought to be considered in this population regarding their important prognostic impact.
No takes yet. Share an insight, caveat, or question.
Bonanad et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: